Sex hormone‐binding globulin as a marker for the thrombotic risk of hormonal contraceptives
M. RAPS(Leiden University Medical Center), Huib van Vliet(Radboud University Nijmegen), Frans M. Helmerhorst(Leiden University Medical Center), Kathrin Fleischer(Helmholtz Zentrum München), Bart E.P.B. Ballieux(Leiden University Medical Center), Stella Thomassen(Maastricht University), Jan Rosing(Maastricht University), Frits R. Rosendaal(Leiden University Medical Center)
Cited by 86
Related Papers
Incidence and mortality of venous thrombosis: a population‐based study
|Journal of Thrombosis and Haemostasis|2007|1.4k
Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study
|The Lancet|2011|1.3k
Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation
|The Lancet|1994|1.1k
Hyperhomocysteinemia as a Risk Factor for Deep-Vein Thrombosis
|New England Journal of Medicine|1996|1.1k